0001493152-24-003097.txt : 20240119
0001493152-24-003097.hdr.sgml : 20240119
20240119172254
ACCESSION NUMBER: 0001493152-24-003097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240117
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frelick Jeff
CENTRAL INDEX KEY: 0001645093
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40899
FILM NUMBER: 24546497
MAIL ADDRESS:
STREET 1: 1 FOX RUN LANE,
CITY: LEXINGTON
STATE: MA
ZIP: 02420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bone Biologics Corp
CENTRAL INDEX KEY: 0001419554
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 421743430
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 BURLINGTON WOODS DRIVE,
STREET 2: SUITE 100,
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 552-4452
MAIL ADDRESS:
STREET 1: 2 BURLINGTON WOODS DRIVE,
STREET 2: SUITE 100,
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: Bone Biologics, Corp.
DATE OF NAME CHANGE: 20140924
FORMER COMPANY:
FORMER CONFORMED NAME: AFH ACQUISITION X, INC.
DATE OF NAME CHANGE: 20071127
4
1
ownership.xml
X0508
4
2024-01-17
0
0001419554
Bone Biologics Corp
BBLG
0001645093
Frelick Jeff
C/O BONE BIOLOGICS CORP
2 BURLINGTON WOODS DR. SUITE 100
BURLINGTON
MA
01803
0
1
0
0
Chief Executive Officer
0
Common Stock
2151
D
Employee Stock Option
3.61
2024-01-17
4
A
0
25000
0.00
A
2024-01-17
2026-01-17
Common Stock
25000
25000
D
Employee Stock Option
9540.00
2025-12-27
Common Stock
173
173
D
Employee Stock Option
12300.00
2026-05-26
Common Stock
44
44
D
Employee Stock Option
892.80
2025-01-01
Common Stock
208
208
D
Employee Stock Option
57.60
2025-01-25
Common Stock
157
157
D
This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
This option is fully vested as of the date of this report.
/s/ Jeffrey Frelick
2024-01-19